Dr Mir Shahnawaz, founder of DERMIS, recently discussed advances in treating atopic dermatitis at the RAD Symposium in Jaipur. India’s top dermatologists attended the event, which focused on groundbreaking developments in skin health and innovative treatments. A key highlight was the discussion on Abrocitinib, a JAK1 inhibitor, which has shown promising results for treating moderate to severe atopic dermatitis. Atopic ...